AbbVie Inc (ABBV)
166.43
+2.08
(+1.27%)
USD |
NYSE |
May 17, 16:00
166.64
+0.21
(+0.13%)
Pre-Market: 08:20
AbbVie Research and Development Expense (TTM): 7.322B for March 31, 2024
Research and Development Expense (TTM) Chart
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| March 31, 2024 | 7.322B |
| December 31, 2023 | 7.675B |
| September 30, 2023 | 7.538B |
| June 30, 2023 | 7.429B |
| March 31, 2023 | 7.305B |
| December 31, 2022 | 6.51B |
| September 30, 2022 | 6.547B |
| June 30, 2022 | 6.594B |
| March 31, 2022 | 6.752B |
| December 31, 2021 | 6.922B |
| September 30, 2021 | 6.807B |
| June 30, 2021 | 6.852B |
| March 31, 2021 | 6.667B |
| December 31, 2020 | 6.379B |
| September 30, 2020 | 6.209B |
| June 30, 2020 | 6.788B |
| March 31, 2020 | 6.497B |
| December 31, 2019 | 6.407B |
| September 30, 2019 | 11.36B |
| June 30, 2019 | 10.34B |
| March 31, 2019 | 10.37B |
| December 31, 2018 | 10.33B |
| September 30, 2018 | 5.242B |
| June 30, 2018 | 5.202B |
| March 31, 2018 | 5.109B |
| Date | Value |
|---|---|
| December 31, 2017 | 5.007B |
| September 30, 2017 | 4.808B |
| June 30, 2017 | 4.686B |
| March 31, 2017 | 4.581B |
| December 31, 2016 | 4.385B |
| September 30, 2016 | 4.251B |
| June 30, 2016 | 4.563B |
| March 31, 2016 | 4.42B |
| December 31, 2015 | 4.285B |
| September 30, 2015 | 4.089B |
| June 30, 2015 | 3.483B |
| March 31, 2015 | 3.336B |
| December 31, 2014 | 3.297B |
| September 30, 2014 | 3.216B |
| June 30, 2014 | 3.118B |
| March 31, 2014 | 2.993B |
| December 31, 2013 | 2.855B |
| September 30, 2013 | 2.738B |
| June 30, 2013 | 2.837B |
| March 31, 2013 | 2.77B |
| December 31, 2012 | 2.778B |
| September 30, 2012 | 2.873B |
| June 30, 2012 | 2.725B |
| March 31, 2012 | 2.673B |
| December 31, 2011 | 2.618B |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
6.209B
Minimum
Sep 2020
11.36B
Maximum
Sep 2019
7.245B
Average
6.798B
Median
Research and Development Expense (TTM) Benchmarks
| Amgen Inc | 5.069B |
| Johnson & Johnson | 15.30B |
| Eli Lilly and Co | 9.851B |
| Merck & Co Inc | 30.25B |
| Pfizer Inc | 10.67B |